{"gene":"RORA","run_date":"2026-06-10T06:43:37","timeline":{"discoveries":[{"year":2005,"finding":"RORα directly activates transcription of Bmal1 through two conserved ROR-response elements (ROREs) in the Bmal1 promoter, functioning as a positive component of the cell-autonomous core circadian clock. Loss of endogenous RORα protein dampens circadian rhythm of Bmal1 transcription.","method":"Transient transfection reporter assays, RORE mutagenesis, RNAi knockdown in cultured cells, behavioral analysis of RORα-deficient staggerer mice","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (reporter assay with mutagenesis, RNAi, in vivo genetic mouse model) in a single focused study","pmids":["15821743"],"is_preprint":false},{"year":2001,"finding":"RORα1 inhibits TNFα-induced IL-6, IL-8, and COX-2 expression in smooth-muscle cells by reducing p65 translocation and transcriptionally upregulating IκBα via a ROR response element in the IκBα promoter, thereby negatively interfering with the NF-κB signaling pathway.","method":"Adenoviral overexpression, Western blotting, immunostaining, EMSA, promoter reporter assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (EMSA, reporter assay, immunostaining, Western blot) in a single rigorous study demonstrating direct RORE-mediated IκBα transactivation","pmids":["11252722"],"is_preprint":false},{"year":2006,"finding":"In SCA1 mice, mutant ATXN1 destabilizes RORα, depleting it from Purkinje cells and reducing expression of RORα-controlled genes. Evidence points to existence of a complex containing ATXN1, RORα, and the RORα coactivator Tip60, linking RORα and Tip60 to SCA1 pathogenesis.","method":"Conditional transgenic mouse model, Co-immunoprecipitation, gene expression analysis, behavioral assessment","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and conditional mouse model, single lab, two orthogonal approaches","pmids":["17110330"],"is_preprint":false},{"year":1998,"finding":"Targeted disruption of the Rora DNA-binding domain produces mice that phenocopy staggerer mice, demonstrating that staggerer defects are caused by absence of functional RORα protein; the null allele fails to complement staggerer, establishing sg as a loss-of-function allele of Rora.","method":"Gene targeting in ES cells (null mutation), histological analysis, Northern blot, complementation testing","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — clean genetic null generation with complementation testing and histological/molecular validation","pmids":["9510031"],"is_preprint":false},{"year":2004,"finding":"RORα directly regulates the carnitine palmitoyltransferase-1 (CPT-1) and caveolin-3 promoters in skeletal muscle cells, with activity coactivated by p300 and PGC-1, implicating RORα in control of lipid homeostasis in skeletal muscle.","method":"Dominant-negative RORα expression, promoter reporter assays, coactivator cotransfection","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter assays with dominant-negative, single lab, two orthogonal methods","pmids":["15199055"],"is_preprint":false},{"year":2002,"finding":"RORα regulates Reverb-α (NR1D1) transcription via a monomeric ROR response element in the Reverb-α promoter; RORα binds this site (demonstrated by EMSA), and GRIP-1/TIF-2 (but not SRC-1) coactivates RORα-stimulated Reverb-α promoter activity.","method":"Northern blot, RT-PCR in staggerer mice, transient transfection reporter assays, EMSA, promoter mutagenesis, coactivator cotransfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — EMSA demonstrating direct DNA binding, mutagenesis of RORE, reporter assays, and genetic validation in staggerer mice; multiple orthogonal methods","pmids":["12114512"],"is_preprint":false},{"year":2007,"finding":"RORα positively regulates Cyp7b1 (oxysterol 7α-hydroxylase) transcription via ROREs in its promoter; loss of RORα in staggerer mice suppresses Cyp7b1 expression and increases LXRα target gene expression. RORα and LXRα mutually suppress each other in vivo.","method":"RORα null (staggerer) mouse analysis, promoter reporter assays, transfection of RORα in hepatocytes, LXR null mouse comparison","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo genetic null combined with promoter reporter assays and reciprocal LXR null comparison, multiple orthogonal methods","pmids":["18055760"],"is_preprint":false},{"year":2011,"finding":"RORα is a direct transcriptional target of p53 (contains functional p53 response elements); DNA damage-induced RORα stabilizes p53 in a HAUSP/Usp7-dependent manner and activates a subset of p53 target genes specifically involved in apoptosis.","method":"Genome-wide screen, luciferase reporter assays with p53-RE mutagenesis, microarray analysis, Drosophila in vivo apoptosis model","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (reporter/mutagenesis, microarray, in vivo Drosophila model) in a single rigorous study","pmids":["22152482"],"is_preprint":false},{"year":2012,"finding":"RORα directly regulates SEMA3F transcription (demonstrated by ChIP and luciferase reporter assay) in breast cancer cells; restoring RORα expression reprograms cancer cells and inhibits tumor invasion in a SEMA3F-dependent manner in 3D culture and nude mouse xenograft.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, 3D culture, siRNA knockdown, xenograft","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct promoter occupancy, reporter assay, in vitro and in vivo functional rescue experiments","pmids":["22350413"],"is_preprint":false},{"year":2014,"finding":"RORα binds to the heptad repeat and marked box region of E2F1 in a non-canonical pathway, suppressing E2F1-regulated transcription; RORα recruits HDAC1 to the complex to inhibit E2F1 acetylation and DNA-binding activity, thereby inhibiting cell cycle progression.","method":"Co-immunoprecipitation, domain mapping, HDAC inhibition rescue, reporter assays, siRNA knockdown in mammary epithelial cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reciprocal Co-IP with domain mapping, HDAC rescue, and in vivo mammary phenotype, multiple orthogonal methods","pmids":["24891616"],"is_preprint":false},{"year":2017,"finding":"Hepatic RORα controls lipid homeostasis by specifically binding and recruiting HDAC3 to PPARγ target gene promoters, causing transcriptional repression of PPARγ; liver-specific Rorα deletion leads to dysregulation of PPARγ signaling, hepatic steatosis, obesity, and insulin resistance on high-fat diet.","method":"Liver-specific Rorα knockout mice, global transcriptome analysis, ChIP, Co-immunoprecipitation with HDAC3, PPARγ antagonist rescue","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — tissue-specific KO with transcriptome, ChIP showing direct promoter occupancy, Co-IP with HDAC3, and pharmacological rescue","pmids":["28757615"],"is_preprint":false},{"year":2017,"finding":"RORα/HDAC3 co-recruitment to NF-κB target gene promoters causes dismissal of CBP and BRD4, thereby repressing NF-κB transcriptional activity in intestinal epithelial cells; IEC-specific RORα deletion leads to excessive intestinal inflammation.","method":"IEC-specific RORα knockout mice, transcriptome analysis, ChIP, DSS colitis model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — tissue-specific KO with transcriptomics and ChIP showing direct chromatin occupancy with identified co-regulators","pmids":["31570593"],"is_preprint":false},{"year":2019,"finding":"Maresin 1 (MaR1), a DHA metabolite, was identified as an endogenous ligand of RORα that enhances RORα expression and transcriptional activity; RORα in turn transcriptionally induces 12-lipoxygenase (12-LOX), a key enzyme in MaR1 biosynthesis, forming a MaR1/RORα/12-LOX autoregulatory circuit.","method":"Ligand-binding assays, reporter assays, ChIP, RORα-dependent MaR1 protection experiments in vivo","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays and ChIP, single lab, in vitro and in vivo evidence, but ligand-receptor interaction validation is partially indirect","pmids":["30855276"],"is_preprint":false},{"year":2014,"finding":"20-hydroxyvitamin D3 [20(OH)D3] and 20,23-dihydroxyvitamin D3 function as antagonists/inverse agonists of RORα, inhibiting RORE-driven reporter activity and RORα-target gene (Bmal1, G6pase) promoter activation; molecular modeling with the RORα LBD crystal structure predicts good binding.","method":"Tet-on RORα expression system + RORE-LUC reporter, mammalian 2-hybrid LBD-LXXLL assay, molecular modeling using LBD crystal structure","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional reporter assays with LBD interaction assay and molecular modeling, single lab","pmids":["24668754"],"is_preprint":false},{"year":2015,"finding":"RORα directly suppresses SOCS3 gene transcription; loss of RORα leads to decreased proinflammatory and increased anti-inflammatory cytokines in retinopathy. Inhibition of SOCS3 abolishes the vasoprotective effects of RORα deficiency, establishing RORα→SOCS3 as a pathway in pathological retinal angiogenesis.","method":"RORα genetic deficiency mouse model (oxygen-induced retinopathy), promoter reporter assays, siRNA inhibition of SOCS3","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO, reporter assay, and SOCS3 rescue, single lab","pmids":["26243880"],"is_preprint":false},{"year":2017,"finding":"RORα directly binds to a specific ROR response element on the Sema3e promoter and negatively regulates Sema3e promoter-driven transcription; genetic deficiency of RORα induces Sema3e expression in retinal ganglion cells to suppress pathological retinal neovascularization.","method":"Promoter-driven luciferase reporter assay, ChIP, AAV2-shRNA knockdown of Sema3e in RORα-deficient mice","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — ChIP and reporter assay with direct functional rescue, single lab","pmids":["28646017"],"is_preprint":false},{"year":2009,"finding":"RORα directly trans-activates the Il-6 gene in astrocytes (necessary for basal IL-6 levels); after inflammatory stimulation, absence of RORα results in excessive IL-6 upregulation via indirect repression of NF-κB signaling, demonstrating bi-directional regulation of IL-6 by RORα.","method":"RORα loss-of-function mutant mice (staggerer), reporter assays, cytokine measurement, immunostaining","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mouse model with reporter assays and cytokine analysis, single lab","pmids":["19955433"],"is_preprint":false},{"year":2009,"finding":"Overexpression of RORα4 in 3T3-L1 cells impairs adipogenesis (decreased adipogenic markers and lipid accumulation); mouse embryonic fibroblasts from staggerer mice differentiate more efficiently into adipocytes, a phenotype reversed by ectopic RORα4 restoration.","method":"Overexpression in 3T3-L1, staggerer MEF differentiation assay, ectopic RORα4 rescue","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with rescue experiment in matched cell lines, single lab","pmids":["19450581"],"is_preprint":false},{"year":2006,"finding":"Subcellular localization of RORα is isoform- and cell line-dependent: RORα1 localizes exclusively to the nucleus (lacks cytoplasmic signal in its A/B domain), while RORα2, 3, and 4 show cytoplasmic and cell-membrane association. The C-terminal α-helix 12 mediates membrane association; the hinge region/LBD mediates nuclear localization.","method":"Isoform-specific expression constructs, domain deletion/swap experiments, subcellular fractionation, immunofluorescence microscopy","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-swap localization experiments with multiple isoforms, single lab","pmids":["16806533"],"is_preprint":false},{"year":1997,"finding":"The staggerer mutation is a deletion in the common coding region of RORα isoforms; RORα1 and RORα4 are specifically co-expressed in the murine and human cerebellum, generated by alternative promoter usage and exon splicing, indicating that loss of both isoforms underlies the cerebellar phenotype.","method":"High-resolution genetic and physical mapping, RT-PCR isoform analysis, Northern blot in cerebellum","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mapping and molecular characterization, single study, direct mutational analysis","pmids":["9226375"],"is_preprint":false},{"year":2022,"finding":"RORα cooperatively binds with RORγt to a previously unidentified Rorc cis-regulatory element to maintain RORγt expression and Th17 lineage stability in peripheral tissues; RORα is dispensable for initial Th17 differentiation but required for optimal Th17 responses in vivo.","method":"T-cell-specific RORα conditional KO mice, RNA-seq, ATAC-seq, ChIP-seq","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — conditional KO with ChIP-seq, ATAC-seq, and RNA-seq providing genome-wide mechanistic evidence, single lab with multiple orthogonal methods","pmids":["36243007"],"is_preprint":false},{"year":2021,"finding":"In skin-resident Tregs, RORα suppresses IL-4 expression and enhances DR3 (death receptor 3/TL1A receptor) expression; deletion of RORα in Tregs prevents sequestration of TL1A, resulting in enhanced ILC2 activation and exaggerated eosinophilia.","method":"Treg-specific RORα conditional deletion mouse models of atopic dermatitis, flow cytometry, cytokine measurement","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with two atopic dermatitis models, single lab","pmids":["29500225"],"is_preprint":false},{"year":2021,"finding":"RORα is required for TH17 cell pathogenicity independent of RORγt; T-cell-specific deletion of RORα reduces EAE and colitis development by decreasing TH17 cell development, lowering tissue-homing chemokine receptors/integrins, and increasing Foxp3+ Tregs. A selective RORα antagonist phenocopies the genetic deletion and inhibits human TH17 differentiation.","method":"T-cell-specific Rorα conditional KO, EAE and colitis mouse models, pharmacological antagonism with selective small molecule, human TH17 differentiation assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with two disease models replicated pharmacologically and extended to human cells, multiple orthogonal approaches","pmids":["33397953"],"is_preprint":false},{"year":2021,"finding":"RORα expression in thymic progenitors represses T cell development while promoting ILC2 development; mechanistically, RORα overrides BCL11B-mediated repression of Nfil3 and Id2, allowing ID2 to repress E proteins and promote ILC2 differentiation over T cell commitment.","method":"RNA-seq, ATAC-seq, ChIP-seq, conditional deletion and overexpression mouse models","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-wide ChIP-seq/ATAC-seq/RNA-seq combined with genetic mouse models establishing a transcriptional circuit","pmids":["33432227"],"is_preprint":false},{"year":2021,"finding":"RORα promotes mTORC1 activation in CD4+ T cells; genome-wide occupancy (ChIP-seq) and transcriptome analysis reveal RORα as a direct transcriptional driver of mTORC1 pathway genes; Rorα deficiency in CD4+ T cells greatly reduces T cell-mediated colitis.","method":"CD4-specific Rorα conditional KO, genome-wide ChIP-seq, RNA-seq, T-cell transfer colitis model","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — conditional KO with genome-wide ChIP-seq and transcriptome, single lab, multiple orthogonal methods","pmids":["34525365"],"is_preprint":false},{"year":2017,"finding":"RORα directly represses IL-6 transcription in cardiomyocytes; loss of RORα leads to enhanced IL-6 expression, proinflammatory STAT3 activation, decreased mitochondrial number and function, oxidative stress, hypertrophy, and death of cardiomyocytes upon angiotensin II exposure.","method":"Staggerer mouse model (in vivo), neonatal rat ventricular myocyte overexpression/silencing (in vitro), luciferase reporter, Western blot","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mouse model complemented by in vitro gain/loss-of-function and reporter assays, single lab","pmids":["30387679"],"is_preprint":false},{"year":2017,"finding":"RORα enhances mitochondrial quality by regulating expression of Bnip3 and PGC-1α; liver-specific RORα knockout mice show mitochondrial fission defects with downregulation of Bnip3 and phospho-Drp1, and are more susceptible to NASH.","method":"Liver-specific Rorα KO mice, high-fat diet NASH model, gene expression analysis, oxygen consumption measurement","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO with functional metabolic readouts, single lab","pmids":["29167529"],"is_preprint":false},{"year":2021,"finding":"RORα induces transcription of Atp6v1g1 (a vacuolar H+-ATPase subunit) and other lysosomal function genes, thereby enhancing lysosomal acidification and autophagic flux in hepatocytes; hepatocyte-specific RORα deletion impairs lysosomal acidity, mTOR translocation, cathepsin D maturation, and autophagic flux.","method":"Hepatocyte-specific Rorα KO mice, LysoSensor assay, LC3/p62/NBR1 accumulation, adenoviral RORα restoration","journal":"Hepatology communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO with adenoviral rescue and multiple lysosomal readouts, single lab","pmids":["34558854"],"is_preprint":false},{"year":2016,"finding":"RORα regulates macrophage M2 polarization via activation of AMPKα; RORα agonist (cholesterol sulfate) induces M2 markers (Arg1, Ym1, Fizz1) and phosphorylation of AMPKα/ACC; RORα antagonism or AMPKα inhibition abolishes this effect.","method":"RORα agonist/antagonist pharmacology in RAW264.7 cells, RORα overexpression, AMPKα inhibitor (Compound C)","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — pharmacological and overexpression approaches with rescue by pathway inhibitor, single lab","pmids":["27788394"],"is_preprint":false},{"year":2019,"finding":"RORα protects against LPS-induced inflammation by regulating SIRT1 expression, which in turn affects deacetylation and nuclear translocation of NF-κB p65; specifically, RORα overexpression suppresses acetylation of NF-κB p65 at lysine 310 via SIRT1 upregulation.","method":"Lentiviral overexpression/siRNA knockdown in macrophages, LPS model in vivo, SIRT1 agonist rescue experiment","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic rescue with SIRT1 agonist in gain- and loss-of-function settings, single lab","pmids":["31071300"],"is_preprint":false},{"year":2024,"finding":"RORA binds the CD274 (PD-L1) promoter and forms an inhibitory complex with HDAC3 to suppress PD-L1 expression; DDX3X competes with HDAC3 for binding to RORA, and DDX3X overexpression promotes RORA release from the repressive complex, increasing PD-L1 expression.","method":"ChIP, Co-immunoprecipitation, overexpression/knockdown in melanoma cells, RORA agonist combined with anti-CTLA4 in vivo","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct promoter occupancy, Co-IP establishing the RORA/HDAC3/DDX3X complex, and in vivo pharmacological validation","pmids":["38718296"],"is_preprint":false},{"year":2021,"finding":"RORα suppresses superoxide generation in mitochondria by directly targeting respiratory complex I subunit genes NDUFS6 and NDUFA11 (identified by ChIP and gene co-expression), thereby inhibiting ROS-mediated macrophage infiltration and cancer-associated inflammation in breast cancer.","method":"Gene co-expression analysis, ChIP, co-culture assay, 4T1 xenograft","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP showing direct promoter occupancy of NDUFS6/NDUFA11, functional co-culture and in vivo validation, single lab","pmids":["34639006"],"is_preprint":false},{"year":2013,"finding":"Neoruscogenin (a steroidal sapogenin) was identified as a potent, high-affinity, bioavailable agonist of RORα (NR1F1) using cell-free reporter assays; it activates RORα target gene expression in vitro and in vivo with selectivity over other nuclear receptors.","method":"High-throughput cell-free RORα reporter screening, extract deconvolution, structural elucidation, target gene expression assays in vitro and in vivo, nuclear receptor selectivity panel","journal":"Journal of biomolecular screening","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based reporter and in vivo target gene validation, single lab","pmids":["23896689"],"is_preprint":false},{"year":2020,"finding":"RORA agonist RS-2982 increases hepatic MIR122 promoter activity in hepatocytes; in HFD and atherogenic diet mouse models, RS-2982 increases hepatic MIR122 precursors and reduces hepatic triglyceride biosynthesis by reducing expression of lipogenic enzymes.","method":"Chemical library screen, luciferase reporter assays (MIR122 promoter), HFD/atherogenic diet mouse models, in vivo injection","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with in vivo mouse validation, single lab","pmids":["32450149"],"is_preprint":false},{"year":2019,"finding":"SORBS2 stabilizes RORA mRNA by directly binding to the 3'UTR of RORA mRNA, reducing its degradation; this post-transcriptional regulation of RORA by SORBS2 mediates SORBS2's anti-tumor effects on HCC cells.","method":"RNA immunoprecipitation (RIP), pull-down assay, luciferase reporter (3'UTR), mRNA stability assay","journal":"Liver international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP and pull-down assay with functional validation, single lab","pmids":["31365778"],"is_preprint":false},{"year":2018,"finding":"The barrel cortex phenotype of staggerer mice results from RORα being cell-autonomously required in the thalamus for thalamocortical axon (TCA) cluster organization, and in the somatosensory cortex for dendritic maturation of layer IV neurons; Sema7a, Neph, and Adcy8 are identified as RORα-regulated genes in this process.","method":"Conditional RORα deletion in thalamus or cortex, microarray analysis, histological analysis of barrels/barreloids","journal":"Cerebral cortex","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific conditional deletion with microarray, single lab","pmids":["29040410"],"is_preprint":false},{"year":2024,"finding":"RORA acts as a CEC-specific molecular switch driving limbal stem cell (LSC) differentiation into corneal epithelial cells by activating PITX1; RORA establishes CEC-specific enhancers and chromatin interactions between CEC gene promoters and distal regulatory elements, while silencing LSC-specific promoters and disrupting promoter-anchored chromatin loops.","method":"Single-cell RNA-seq, ChIP-seq, ATAC-seq, Hi-C chromatin interaction analysis, RORA gain/loss-of-function","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-wide epigenomic (ChIP-seq, ATAC-seq, Hi-C) plus single-cell transcriptomics with functional validation, multiple orthogonal methods","pmids":["38177186"],"is_preprint":false},{"year":2017,"finding":"RORα and RORγt co-regulate a defined set of human Th17 signature genes including IL-17A, IL-17F, IL-23R, CCL20, and CCR6; siRNA knockdown of RORα in human Th17 cells reduces expression of these key Th17 genes, demonstrating an overlapping but weaker role of RORα versus RORγt.","method":"siRNA knockdown (RORγt, RORα), RNA-seq, selective RORγt small molecule modulators as pharmacological controls","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide RNA-seq with siRNA knockdown, parallel pharmacological validation, single lab","pmids":["28763457"],"is_preprint":false},{"year":2019,"finding":"RORα mediates induction of osteoarthritis by oxysterol metabolites produced by CH25H and CYP7B1 in chondrocytes; overexpression of CH25H or CYP7B1 causes experimental OA, while knockdown abrogates OA pathogenesis, with RORα acting as downstream effector of cholesterol metabolism changes.","method":"Adenoviral overexpression/knockout/knockdown in mouse joints, in vivo OA induction models, epistasis experiments with RORα","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple in vivo genetic manipulation approaches with epistasis placing RORα downstream of CH25H/CYP7B1, replicated in multiple models","pmids":["30728500"],"is_preprint":false},{"year":2014,"finding":"miR-137 directly targets the 3'UTR of RORα in a site-specific manner, establishing a direct biological link between MIR137 and RORA as autism candidate genes.","method":"Luciferase 3'UTR reporter assay with site-specific mutagenesis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, single method (luciferase reporter), but site-specific mutagenesis validates the interaction","pmids":["24500708"],"is_preprint":false},{"year":2020,"finding":"In skeletal muscle, specific knockout of Rorα (secondary feedback loop) results in aberrant expression of a large number of non-oscillating genes and proteins (rather than primarily affecting circadian oscillation), leading to distinct metabolic and contractile phenotypes compared to PER2 knockout.","method":"Muscle-specific Rorα KO mice, global gene expression analysis, metabolomics, muscle function assessment","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with transcriptomics and metabolomics, single lab","pmids":["38850551"],"is_preprint":false}],"current_model":"RORA (RORα) is an orphan nuclear receptor that acts as a constitutively active transcription factor binding monomeric ROR-response elements (ROREs) to directly activate target genes (Bmal1, Cyp7b1, CPT-1, Caveolin-3, IL-6, SEMA3F, Reverb-α, NDUFS6/NDUFA11, PITX1) or repress them by recruiting HDAC3 to displace coactivators (CBP, BRD4) from NF-κB and PPARγ target promoters; in the nucleus it can also engage non-canonical partners (E2F1 via its heptad/marked-box domain + HDAC1; HDAC3/DDX3X on the PD-L1 promoter; ATXN1/Tip60 complex in Purkinje cells), and its activity is modulated by endogenous ligands including oxysterols/cholesterol sulfate and the specialized pro-resolving mediator maresin-1; isoform-specific subcellular localization (nuclear for RORα1 via hinge/LBD; cytoplasmic/membrane for RORα2-4 via helix 12) further regulates its activity, while post-transcriptional control by RNA-binding proteins (SORBS2) and miRNAs modulate its protein levels in disease contexts."},"narrative":{"mechanistic_narrative":"RORA encodes RORα, a ligand-modulated nuclear receptor that acts as a constitutively active transcription factor binding monomeric ROR-response elements (ROREs) to direct cell-type-specific gene programs across circadian, metabolic, immune, and developmental contexts [PMID:15821743, PMID:12114512, PMID:18055760]. As a positive arm of the core circadian clock, RORα directly activates Bmal1 and the clock gene Reverb-α through conserved ROREs, with coactivation by GRIP-1/TIF-2 [PMID:15821743, PMID:12114512]. Genetic disruption of the RORα DNA-binding domain phenocopies and fails to complement the staggerer allele, establishing staggerer as a loss-of-function mutation in the shared coding region of co-expressed cerebellar isoforms [PMID:9510031, PMID:9226375]. Beyond direct activation, RORα executes gene repression by recruiting HDAC3 to displace coactivators CBP and BRD4 from NF-κB target promoters in intestinal epithelium and to silence PPARγ target genes in liver, linking RORα loss to intestinal inflammation, hepatic steatosis, and insulin resistance [PMID:28757615, PMID:31570593]. RORα also represses targets through non-canonical protein partnerships: it binds the heptad/marked-box region of E2F1 and recruits HDAC1 to block E2F1 acetylation and cell-cycle progression, and it forms an HDAC3 complex on the CD274 (PD-L1) promoter that DDX3X antagonizes [PMID:24891616, PMID:38718296]. In the immune system RORα cooperates with RORγt at a Rorc cis-element to stabilize the Th17 lineage and is independently required for Th17 pathogenicity and mTORC1-driven T-cell programs, while in thymic progenitors it directs ILC2 over T-cell fate by overriding BCL11B repression of Nfil3/Id2 [PMID:36243007, PMID:33397953, PMID:33432227, PMID:34525365]. RORα controls lipid and oxysterol metabolism through targets including Cyp7b1, CPT-1, and caveolin-3, with reciprocal antagonism toward LXRα, and serves as the downstream effector of CH25H/CYP7B1-generated oxysterols driving osteoarthritis [PMID:15199055, PMID:18055760, PMID:30728500]. Its activity is tuned by endogenous and synthetic ligands—oxysterols, cholesterol sulfate, hydroxyvitamin D3 metabolites, the pro-resolving mediator maresin-1, and synthetic agonists—and isoform-specific localization, with RORα1 confined to the nucleus and RORα2-4 directed to cytoplasm/membrane by C-terminal helix 12 [PMID:30855276, PMID:24668754, PMID:16806533, PMID:27788394, PMID:30728500].","teleology":[{"year":1997,"claim":"Defining the molecular lesion in staggerer mice established that a deletion in the shared coding region of RORα isoforms, ablating cerebellar RORα1 and RORα4, underlies the cerebellar phenotype.","evidence":"Genetic/physical mapping and RT-PCR isoform analysis in murine and human cerebellum","pmids":["9226375"],"confidence":"Medium","gaps":["Did not establish which downstream transcriptional targets mediate the cerebellar defect","Isoform-specific functional differences not resolved"]},{"year":1998,"claim":"Targeted disruption of the RORα DNA-binding domain proved that staggerer is a loss-of-function allele of Rora, formally tying the phenotype to absent functional RORα protein.","evidence":"Gene targeting in ES cells with complementation testing and histological/Northern validation","pmids":["9510031"],"confidence":"High","gaps":["DNA-binding-independent activities not addressed","Molecular targets in cerebellum not identified"]},{"year":2001,"claim":"First mechanistic link of RORα to inflammation showed it antagonizes NF-κB by transactivating IκBα via a RORE, reducing p65 translocation.","evidence":"Adenoviral overexpression, EMSA, promoter reporter, immunostaining in smooth-muscle cells","pmids":["11252722"],"confidence":"High","gaps":["Coregulators of this repression not defined here","Did not address direct vs indirect NF-κB target repression"]},{"year":2002,"claim":"Established RORα as a direct monomeric-RORE transcription factor for the clock gene Reverb-α with coactivator selectivity, defining its DNA-binding mode.","evidence":"EMSA, RORE mutagenesis, reporter and coactivator cotransfection, staggerer validation","pmids":["12114512"],"confidence":"High","gaps":["Endogenous ligand control of this activity not addressed","Structural basis of GRIP-1 vs SRC-1 selectivity unresolved"]},{"year":2004,"claim":"Extended RORα's direct target repertoire to skeletal-muscle lipid genes CPT-1 and caveolin-3, with p300/PGC-1 coactivation, implicating it in muscle lipid homeostasis.","evidence":"Dominant-negative RORα, promoter reporter, coactivator cotransfection","pmids":["15199055"],"confidence":"Medium","gaps":["Direct promoter occupancy not shown by ChIP","In vivo metabolic relevance not tested"]},{"year":2005,"claim":"Placed RORα as a positive limb of the core circadian clock by demonstrating direct RORE-driven activation of Bmal1.","evidence":"Reporter assays with RORE mutagenesis, RNAi, and staggerer behavioral analysis","pmids":["15821743"],"confidence":"High","gaps":["Ligand regulation of clock activity not addressed","Tissue-specific contributions not dissected"]},{"year":2006,"claim":"Connected RORα to neurodegeneration and defined isoform-localization rules, showing mutant ATXN1 destabilizes RORα in Purkinje cells and that helix 12 vs hinge/LBD dictate membrane vs nuclear localization.","evidence":"Conditional transgenic SCA1 model with Co-IP; domain-swap fractionation/immunofluorescence","pmids":["17110330","16806533"],"confidence":"Medium","gaps":["Direct ATXN1-RORA-Tip60 complex stoichiometry not resolved","Functional consequence of cytoplasmic isoforms unclear"]},{"year":2007,"claim":"Defined RORα as a regulator of oxysterol/cholesterol metabolism by directly activating Cyp7b1 and mutually antagonizing LXRα.","evidence":"Staggerer null analysis, promoter reporters, hepatocyte transfection, LXR-null comparison","pmids":["18055760"],"confidence":"High","gaps":["Mechanism of reciprocal RORα/LXRα antagonism not detailed","Ligand identity for endogenous activation not pinned"]},{"year":2011,"claim":"Positioned RORα within the DNA-damage/apoptosis axis as both a p53 target and a stabilizer of p53 via HAUSP/Usp7.","evidence":"Genome-wide screen, p53-RE mutagenesis reporters, microarray, Drosophila apoptosis model","pmids":["22152482"],"confidence":"High","gaps":["Direct RORα-Usp7-p53 biochemistry not fully reconstituted","Selectivity for apoptotic vs other p53 targets unexplained"]},{"year":2014,"claim":"Revealed non-canonical RORα activity by direct binding to E2F1's heptad/marked-box and HDAC1 recruitment to suppress cell-cycle progression, plus identified vitamin D3 derivatives as inverse agonists.","evidence":"Reciprocal Co-IP with domain mapping and HDAC rescue; Tet-on reporter and LBD 2-hybrid with crystal-structure modeling","pmids":["24891616","24668754"],"confidence":"High","gaps":["Generality of E2F1 repression across cell types not established","Vitamin D3 antagonism shown by modeling/reporter, not co-crystal"]},{"year":2017,"claim":"Defined RORα's HDAC3-dependent repressive mode genome-wide, showing co-recruitment to PPARγ and NF-κB target promoters that controls hepatic lipid homeostasis and intestinal inflammation, with parallel roles in mitochondrial quality and cardiomyocyte protection.","evidence":"Tissue-specific KO (liver, IEC), transcriptomics, ChIP, Co-IP with HDAC3, disease models; NRVM gain/loss-of-function","pmids":["28757615","31570593","29167529","30387679"],"confidence":"High","gaps":["Determinants of HDAC3 recruitment to specific promoters unresolved","Coordination of activator vs repressor functions in same cell unclear"]},{"year":2019,"claim":"Identified maresin-1 as an endogenous RORα ligand forming a MaR1/RORα/12-LOX autoregulatory circuit, and linked RORα to SIRT1-mediated NF-κB p65 deacetylation control.","evidence":"Ligand-binding, reporter, ChIP, in vivo MaR1 protection; overexpression/knockdown with SIRT1 agonist rescue","pmids":["30855276","31071300"],"confidence":"Medium","gaps":["MaR1-RORα binding partially indirect, lacks structural confirmation","Physiological relevance of MaR1/12-LOX loop in vivo limited"]},{"year":2021,"claim":"Established RORα as a central regulator of immune cell fate—Th17 pathogenicity, ILC2 vs T-cell commitment, mTORC1 programs, and Treg-mediated TL1A sequestration—largely independent of RORγt.","evidence":"Multiple cell-type-specific conditional KOs with ChIP-seq/ATAC-seq/RNA-seq and disease models (EAE, colitis, atopic dermatitis); selective antagonist in human cells","pmids":["33397953","33432227","34525365","29500225"],"confidence":"High","gaps":["Direct vs indirect targets within each immune program not fully separated","Ligand control of immune RORα activity unaddressed"]},{"year":2024,"claim":"Showed RORα functions as an epigenomic switch establishing cell-type enhancers and chromatin loops, including driving corneal epithelial differentiation via PITX1 and tuning anti-tumor immunity by controlling PD-L1 through an HDAC3/DDX3X-modulated complex.","evidence":"scRNA-seq/ChIP-seq/ATAC-seq/Hi-C with gain/loss-of-function; ChIP and Co-IP with in vivo agonist plus anti-CTLA4","pmids":["38177186","38718296"],"confidence":"High","gaps":["How RORα reorganizes 3D chromatin mechanistically not resolved","Generalizability of PD-L1 DDX3X switch beyond melanoma untested"]},{"year":null,"claim":"How RORα integrates ligand sensing, isoform-specific localization, and the choice between RORE-driven activation versus HDAC-dependent repression to select context-specific gene programs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking ligand identity to activator vs repressor output","Structural basis of partner selection (HDAC3 vs HDAC1 vs DDX3X vs RORγt) undefined","Mechanism directing 3D chromatin remodeling unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,5,6,8,10,11,20,23,36]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,3,5,8,15,31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,10,11,30]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[12,13,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5,18]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[18]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[11,16,20,22,23,24,37]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,6,10,26,33,38]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5,8,10,11,36]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10,11,30,36]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[9]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[27]}],"complexes":[],"partners":["HDAC3","HDAC1","E2F1","DDX3X","RORC","ATXN1","PPARG","SORBS2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35398","full_name":"Nuclear receptor ROR-alpha","aliases":["Nuclear receptor RZR-alpha","Nuclear receptor subfamily 1 group F member 1","RAR-related orphan receptor A","Retinoid-related orphan receptor-alpha"],"length_aa":523,"mass_kda":59.0,"function":"Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator of embryonic development, cellular differentiation, immunity, circadian rhythm as well as lipid, steroid, xenobiotics and glucose metabolism. Considered to have intrinsic transcriptional activity, have some natural ligands like oxysterols that act as agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenated sterols), enhancing or repressing the transcriptional activity, respectively. Recruits distinct combinations of cofactors to target genes regulatory regions to modulate their transcriptional expression, depending on the tissue, time and promoter contexts. Regulates genes involved in photoreceptor development including OPN1SW, OPN1SM and ARR3 and skeletal muscle development with MYOD1. Required for proper cerebellum development (PubMed:29656859). Regulates SHH gene expression, among others, to induce granule cells proliferation as well as expression of genes involved in calcium-mediated signal transduction. Regulates the circadian expression of several clock genes, including CLOCK, BMAL1, NPAS2 and CRY1. Competes with NR1D1 for binding to their shared DNA response element on some clock genes such as BMAL1, CRY1 and NR1D1 itself, resulting in NR1D1-mediated repression or RORA-mediated activation of clock genes expression, leading to the circadian pattern of clock genes expression. Therefore influences the period length and stability of the clock. Regulates genes involved in lipid metabolism such as apolipoproteins APOA1, APOA5, APOC3 and PPARG. In liver, has specific and redundant functions with RORC as positive or negative modulator of expression of genes encoding phase I and phase II proteins involved in the metabolism of lipids, steroids and xenobiotics, such as CYP7B1 and SULT2A1. Induces a rhythmic expression of some of these genes. In addition, interplays functionally with NR1H2 and NR1H3 for the regulation of genes involved in cholesterol metabolism. Also involved in the regulation of hepatic glucose metabolism through the modulation of G6PC1 and PCK1. In adipose tissue, plays a role as negative regulator of adipocyte differentiation, probably acting through dual mechanisms. May suppress CEBPB-dependent adipogenesis through direct interaction and PPARG-dependent adipogenesis through competition for DNA-binding. Downstream of IL6 and TGFB and synergistically with RORC isoform 2, is implicated in the lineage specification of uncommitted CD4(+) T-helper (T(H)) cells into T(H)17 cells, antagonizing the T(H)1 program. Probably regulates IL17 and IL17F expression on T(H) by binding to the essential enhancer conserved non-coding sequence 2 (CNS2) in the IL17-IL17F locus. Involved in hypoxia signaling by interacting with and activating the transcriptional activity of HIF1A. May inhibit cell growth in response to cellular stress. May exert an anti-inflammatory role by inducing CHUK expression and inhibiting NF-kappa-B signaling","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P35398/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RORA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RORA","total_profiled":1310},"omim":[{"mim_id":"621248","title":"PULMONARY HYPERTENSION, PRIMARY, 7; PPH7","url":"https://www.omim.org/entry/621248"},{"mim_id":"619677","title":"CLAUDIN DOMAIN-CONTAINING PROTEIN 1; CLDND1","url":"https://www.omim.org/entry/619677"},{"mim_id":"618060","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA","url":"https://www.omim.org/entry/618060"},{"mim_id":"617138","title":"SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 2; SKOR2","url":"https://www.omim.org/entry/617138"},{"mim_id":"615354","title":"LIGAND-DEPENDENT NUCLEAR RECEPTOR-INTERACTING FACTOR 1; LRIF1","url":"https://www.omim.org/entry/615354"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skin 1","ntpm":77.7}],"url":"https://www.proteinatlas.org/search/RORA"},"hgnc":{"alias_symbol":["RZRA","ROR1","ROR2","ROR3","NR1F1","ROR-alpha","RORalpha","RORa1","RORα"],"prev_symbol":[]},"alphafold":{"accession":"P35398","domains":[{"cath_id":"3.30.50.10","chopping":"63-146","consensus_level":"high","plddt":89.4131,"start":63,"end":146},{"cath_id":"1.10.565.10","chopping":"270-511","consensus_level":"high","plddt":95.8036,"start":270,"end":511}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35398","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35398-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35398-F1-predicted_aligned_error_v6.png","plddt_mean":75.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RORA","jax_strain_url":"https://www.jax.org/strain/search?query=RORA"},"sequence":{"accession":"P35398","fasta_url":"https://rest.uniprot.org/uniprotkb/P35398.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35398/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35398"}},"corpus_meta":[{"pmid":"15821743","id":"PMC_15821743","title":"The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1.","date":"2005","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15821743","citation_count":401,"is_preprint":false},{"pmid":"30728500","id":"PMC_30728500","title":"The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30728500","citation_count":255,"is_preprint":false},{"pmid":"11252722","id":"PMC_11252722","title":"The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response.","date":"2001","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11252722","citation_count":241,"is_preprint":false},{"pmid":"24668754","id":"PMC_24668754","title":"RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24668754","citation_count":238,"is_preprint":false},{"pmid":"17110330","id":"PMC_17110330","title":"RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17110330","citation_count":194,"is_preprint":false},{"pmid":"9510031","id":"PMC_9510031","title":"Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9510031","citation_count":156,"is_preprint":false},{"pmid":"15199055","id":"PMC_15199055","title":"RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15199055","citation_count":146,"is_preprint":false},{"pmid":"30855276","id":"PMC_30855276","title":"A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30855276","citation_count":130,"is_preprint":false},{"pmid":"28757615","id":"PMC_28757615","title":"RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28757615","citation_count":126,"is_preprint":false},{"pmid":"27693422","id":"PMC_27693422","title":"Endogenously produced nonclassical vitamin D hydroxy-metabolites act as \"biased\" agonists on VDR and inverse agonists on RORα and RORγ.","date":"2016","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27693422","citation_count":122,"is_preprint":false},{"pmid":"28763457","id":"PMC_28763457","title":"RORγt and RORα signature genes in human Th17 cells.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28763457","citation_count":114,"is_preprint":false},{"pmid":"12966220","id":"PMC_12966220","title":"Dynamic patterned expression of orphan nuclear receptor genes RORalpha and RORbeta in developing mouse forebrain.","date":"2003","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12966220","citation_count":108,"is_preprint":false},{"pmid":"29500225","id":"PMC_29500225","title":"RORα-expressing T regulatory cells restrain allergic skin inflammation.","date":"2018","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29500225","citation_count":107,"is_preprint":false},{"pmid":"22350413","id":"PMC_22350413","title":"RORα suppresses breast tumor invasion by inducing SEMA3F expression.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22350413","citation_count":100,"is_preprint":false},{"pmid":"18055760","id":"PMC_18055760","title":"Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18055760","citation_count":91,"is_preprint":false},{"pmid":"31816636","id":"PMC_31816636","title":"Single-cell analysis of RORα tracer mouse lung reveals ILC progenitors and effector ILC2 subsets.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31816636","citation_count":90,"is_preprint":false},{"pmid":"36243007","id":"PMC_36243007","title":"Transcription factor RORα enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element.","date":"2022","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/36243007","citation_count":81,"is_preprint":false},{"pmid":"16427031","id":"PMC_16427031","title":"ROR alpha in genetic control of cerebellum development: 50 staggering years.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16427031","citation_count":79,"is_preprint":false},{"pmid":"33432227","id":"PMC_33432227","title":"RORα is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33432227","citation_count":75,"is_preprint":false},{"pmid":"32450149","id":"PMC_32450149","title":"Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.","date":"2020","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/32450149","citation_count":74,"is_preprint":false},{"pmid":"22152482","id":"PMC_22152482","title":"DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22152482","citation_count":71,"is_preprint":false},{"pmid":"30093563","id":"PMC_30093563","title":"miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer.","date":"2018","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/30093563","citation_count":70,"is_preprint":false},{"pmid":"26056561","id":"PMC_26056561","title":"Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism.","date":"2015","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/26056561","citation_count":68,"is_preprint":false},{"pmid":"19955433","id":"PMC_19955433","title":"The nuclear receptor ROR(alpha) exerts a bi-directional regulation of IL-6 in resting and reactive astrocytes.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19955433","citation_count":67,"is_preprint":false},{"pmid":"10404252","id":"PMC_10404252","title":"Cerebellar Purkinje cell loss during life span of the heterozygous staggerer mouse (Rora(+)/Rora(sg)) is gender-related.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10404252","citation_count":66,"is_preprint":false},{"pmid":"31570593","id":"PMC_31570593","title":"RORα is crucial for attenuated inflammatory response to maintain intestinal homeostasis.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31570593","citation_count":65,"is_preprint":false},{"pmid":"9226375","id":"PMC_9226375","title":"The structural integrity of ROR alpha isoforms is mutated in staggerer mice: cerebellar coexpression of ROR alpha1 and ROR alpha4.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9226375","citation_count":64,"is_preprint":false},{"pmid":"26243880","id":"PMC_26243880","title":"Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26243880","citation_count":61,"is_preprint":false},{"pmid":"27542227","id":"PMC_27542227","title":"RORα and RORγ expression inversely correlates with human melanoma progression.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27542227","citation_count":58,"is_preprint":false},{"pmid":"11850116","id":"PMC_11850116","title":"Age-related phenotypes in the staggerer mouse expand the RORalpha nuclear receptor's role beyond the cerebellum.","date":"2002","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11850116","citation_count":58,"is_preprint":false},{"pmid":"32062354","id":"PMC_32062354","title":"MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway.","date":"2020","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/32062354","citation_count":57,"is_preprint":false},{"pmid":"12114512","id":"PMC_12114512","title":"Identification of Reverb(alpha) as a novel ROR(alpha) target gene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12114512","citation_count":53,"is_preprint":false},{"pmid":"16818384","id":"PMC_16818384","title":"RORalpha, a pivotal nuclear receptor for Purkinje neuron survival and differentiation: from development to ageing.","date":"2006","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16818384","citation_count":51,"is_preprint":false},{"pmid":"33397953","id":"PMC_33397953","title":"Genetic and pharmacological inhibition of the nuclear receptor RORα regulates TH17 driven inflammatory disorders.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33397953","citation_count":49,"is_preprint":false},{"pmid":"32207044","id":"PMC_32207044","title":"Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma.","date":"2020","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32207044","citation_count":49,"is_preprint":false},{"pmid":"11821045","id":"PMC_11821045","title":"Expression and regulation of the nuclear receptor RORalpha in human vascular cells.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11821045","citation_count":46,"is_preprint":false},{"pmid":"31365778","id":"PMC_31365778","title":"The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.","date":"2019","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/31365778","citation_count":45,"is_preprint":false},{"pmid":"24500708","id":"PMC_24500708","title":"A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24500708","citation_count":45,"is_preprint":false},{"pmid":"25789810","id":"PMC_25789810","title":"Investigation of associations between NR1D1, RORA and RORB genes and bipolar disorder.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25789810","citation_count":44,"is_preprint":false},{"pmid":"30485323","id":"PMC_30485323","title":"RORα controls inflammatory state of human macrophages.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30485323","citation_count":44,"is_preprint":false},{"pmid":"34584074","id":"PMC_34584074","title":"Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34584074","citation_count":44,"is_preprint":false},{"pmid":"12023888","id":"PMC_12023888","title":"Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the predominant isoform of the nuclear receptor RORalpha in the liver and is up-regulated by hypoxia in HepG2 human hepatoma cells.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12023888","citation_count":44,"is_preprint":false},{"pmid":"29167529","id":"PMC_29167529","title":"Liver-specific deletion of RORα aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29167529","citation_count":43,"is_preprint":false},{"pmid":"34666800","id":"PMC_34666800","title":"CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34666800","citation_count":42,"is_preprint":false},{"pmid":"23896689","id":"PMC_23896689","title":"The identification of naturally occurring neoruscogenin as a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1).","date":"2013","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/23896689","citation_count":42,"is_preprint":false},{"pmid":"32360520","id":"PMC_32360520","title":"Maresin-1 resolution with RORα and LGR6.","date":"2020","source":"Progress in lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/32360520","citation_count":40,"is_preprint":false},{"pmid":"27324142","id":"PMC_27324142","title":"Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1α) and RORA.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27324142","citation_count":39,"is_preprint":false},{"pmid":"34003838","id":"PMC_34003838","title":"Mapping Rora expression in resting and activated CD4+ T cells.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34003838","citation_count":37,"is_preprint":false},{"pmid":"34556887","id":"PMC_34556887","title":"T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34556887","citation_count":37,"is_preprint":false},{"pmid":"24007783","id":"PMC_24007783","title":"The retinoid-related orphan receptor alpha (RORA) gene and fear-related psychopathology.","date":"2013","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24007783","citation_count":36,"is_preprint":false},{"pmid":"18535165","id":"PMC_18535165","title":"The emerging role of nuclear receptor RORalpha and its crosstalk with LXR in xeno- and endobiotic gene regulation.","date":"2008","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/18535165","citation_count":36,"is_preprint":false},{"pmid":"11335003","id":"PMC_11335003","title":"A comparative study of Purkinje cells in two RORalpha gene mutant mice: staggerer and RORalpha(-/-).","date":"2001","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11335003","citation_count":36,"is_preprint":false},{"pmid":"27653902","id":"PMC_27653902","title":"RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis.","date":"2016","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27653902","citation_count":35,"is_preprint":false},{"pmid":"28608249","id":"PMC_28608249","title":"Retinoic acid-related orphan receptor alpha (RORA) variants are associated with autism spectrum disorder.","date":"2017","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/28608249","citation_count":34,"is_preprint":false},{"pmid":"19450581","id":"PMC_19450581","title":"Inhibition of adipocyte differentiation by RORalpha.","date":"2009","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19450581","citation_count":34,"is_preprint":false},{"pmid":"31071300","id":"PMC_31071300","title":"ROR alpha protects against LPS-induced inflammation by down-regulating SIRT1/NF-kappa B pathway.","date":"2019","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/31071300","citation_count":33,"is_preprint":false},{"pmid":"30387679","id":"PMC_30387679","title":"The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.","date":"2018","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30387679","citation_count":33,"is_preprint":false},{"pmid":"38718296","id":"PMC_38718296","title":"The Circadian Clock Component RORA Increases Immunosurveillance in Melanoma by Inhibiting PD-L1 Expression.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38718296","citation_count":32,"is_preprint":false},{"pmid":"34525365","id":"PMC_34525365","title":"RORα is critical for mTORC1 activity in T cell-mediated colitis.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34525365","citation_count":29,"is_preprint":false},{"pmid":"34510508","id":"PMC_34510508","title":"Requirement of RORα for maintenance and antitumor immunity of liver-resident natural killer cells/ILC1s.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/34510508","citation_count":29,"is_preprint":false},{"pmid":"23565190","id":"PMC_23565190","title":"Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23565190","citation_count":27,"is_preprint":false},{"pmid":"33060131","id":"PMC_33060131","title":"The conserved molting/circadian rhythm regulator NHR-23/NR1F1 serves as an essential co-regulator of C. elegans spermatogenesis.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33060131","citation_count":26,"is_preprint":false},{"pmid":"35078435","id":"PMC_35078435","title":"Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.","date":"2022","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35078435","citation_count":26,"is_preprint":false},{"pmid":"34639006","id":"PMC_34639006","title":"RORα Suppresses Cancer-Associated Inflammation by Repressing Respiratory Complex I-Dependent ROS Generation.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34639006","citation_count":26,"is_preprint":false},{"pmid":"35504868","id":"PMC_35504868","title":"POU6F1 cooperates with RORA to suppress the proliferation of lung adenocarcinoma by downregulation HIF1A signaling pathway.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35504868","citation_count":25,"is_preprint":false},{"pmid":"28646017","id":"PMC_28646017","title":"RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28646017","citation_count":24,"is_preprint":false},{"pmid":"22967355","id":"PMC_22967355","title":"Is retinoic acid-related orphan receptor-alpha (RORA) a target for gene-environment interactions contributing to autism?","date":"2012","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/22967355","citation_count":23,"is_preprint":false},{"pmid":"28332183","id":"PMC_28332183","title":"Retinoic acid receptor-related orphan receptor RORα regulates differentiation and survival of keratinocytes during hypoxia.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28332183","citation_count":23,"is_preprint":false},{"pmid":"27788394","id":"PMC_27788394","title":"Retinoid acid receptor-related orphan receptor alpha (RORα) regulates macrophage M2 polarization via activation of AMPKα.","date":"2016","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27788394","citation_count":23,"is_preprint":false},{"pmid":"26812621","id":"PMC_26812621","title":"RORα and 25-Hydroxycholesterol Crosstalk Regulates Lipid Droplet Homeostasis in Macrophages.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26812621","citation_count":23,"is_preprint":false},{"pmid":"35781060","id":"PMC_35781060","title":"Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases.","date":"2022","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/35781060","citation_count":22,"is_preprint":false},{"pmid":"32762066","id":"PMC_32762066","title":"Long non-coding RNA TUG1 participates in LPS-induced periodontitis by regulating miR-498/RORA pathway.","date":"2020","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32762066","citation_count":22,"is_preprint":false},{"pmid":"25798337","id":"PMC_25798337","title":"RORA and posttraumatic stress trajectories: main effects and interactions with childhood physical abuse history.","date":"2015","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/25798337","citation_count":22,"is_preprint":false},{"pmid":"24891616","id":"PMC_24891616","title":"RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24891616","citation_count":22,"is_preprint":false},{"pmid":"33174051","id":"PMC_33174051","title":"lncRNA FGD5 antisense RNA 1 upregulates RORA to suppress hypoxic injury of human cardiomyocyte cells by inhibiting oxidative stress and apoptosis via miR‑195.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33174051","citation_count":22,"is_preprint":false},{"pmid":"38725854","id":"PMC_38725854","title":"Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38725854","citation_count":21,"is_preprint":false},{"pmid":"22104449","id":"PMC_22104449","title":"Altered expression of NFY-C and RORA in colorectal adenocarcinomas.","date":"2011","source":"Acta histochemica","url":"https://pubmed.ncbi.nlm.nih.gov/22104449","citation_count":21,"is_preprint":false},{"pmid":"34558854","id":"PMC_34558854","title":"RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes.","date":"2021","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/34558854","citation_count":21,"is_preprint":false},{"pmid":"35027651","id":"PMC_35027651","title":"Maternal diabetes-mediated RORA suppression in mice contributes to autism-like offspring through inhibition of aromatase.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35027651","citation_count":20,"is_preprint":false},{"pmid":"25892098","id":"PMC_25892098","title":"Associations of PER3 and RORA Circadian Gene Polymorphisms and Depressive Symptoms in Older Adults.","date":"2015","source":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25892098","citation_count":20,"is_preprint":false},{"pmid":"33524877","id":"PMC_33524877","title":"Circ_0081572 inhibits the progression of periodontitis through regulating the miR-378h/RORA axis.","date":"2021","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/33524877","citation_count":20,"is_preprint":false},{"pmid":"22223133","id":"PMC_22223133","title":"RORalpha, a key to the development and functioning of the brain.","date":"2012","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22223133","citation_count":19,"is_preprint":false},{"pmid":"31340215","id":"PMC_31340215","title":"RORA Overexpression Alleviates Nasal Mucosal Injury and Enhances Red Blood Cell Immune Adhesion Function in a Mouse Model of Allergic Rhinitis via Inactivation of the Wnt/β-Catenin Signaling Pathway.","date":"2019","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31340215","citation_count":19,"is_preprint":false},{"pmid":"37051760","id":"PMC_37051760","title":"Targeting RORα in macrophages to boost diabetic bone regeneration.","date":"2023","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/37051760","citation_count":19,"is_preprint":false},{"pmid":"17685489","id":"PMC_17685489","title":"Expression of zebrafish ROR alpha gene in cerebellar-like structures.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17685489","citation_count":17,"is_preprint":false},{"pmid":"29040410","id":"PMC_29040410","title":"RORα Coordinates Thalamic and Cortical Maturation to Instruct Barrel Cortex Development.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29040410","citation_count":17,"is_preprint":false},{"pmid":"27925372","id":"PMC_27925372","title":"CYP19A1, MIF and ABCA1 genes are targets of the RORα in monocyte and endothelial cells.","date":"2017","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/27925372","citation_count":17,"is_preprint":false},{"pmid":"35309302","id":"PMC_35309302","title":"Rora Regulates Neutrophil Migration and Activation in Zebrafish.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35309302","citation_count":16,"is_preprint":false},{"pmid":"37066074","id":"PMC_37066074","title":"Cerebellum and neurodevelopmental disorders: RORα is a unifying force.","date":"2023","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37066074","citation_count":16,"is_preprint":false},{"pmid":"29313974","id":"PMC_29313974","title":"Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29313974","citation_count":16,"is_preprint":false},{"pmid":"33767712","id":"PMC_33767712","title":"Functions for Retinoic Acid-Related Orphan Receptor Alpha (RORα) in the Activation of Macrophages During Lipopolysaccharide-Induced Septic Shock.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33767712","citation_count":16,"is_preprint":false},{"pmid":"32973801","id":"PMC_32973801","title":"Role for Retinoic Acid-Related Orphan Receptor Alpha (RORα) Expressing Macrophages in Diet-Induced Obesity.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32973801","citation_count":15,"is_preprint":false},{"pmid":"28598825","id":"PMC_28598825","title":"Retinoic acid-related orphan receptor alpha (RORA) variants and risk of breast cancer.","date":"2017","source":"Breast disease","url":"https://pubmed.ncbi.nlm.nih.gov/28598825","citation_count":14,"is_preprint":false},{"pmid":"31409890","id":"PMC_31409890","title":"Retinoid-related orphan nuclear receptor alpha (RORα)-deficient mice display morphological testicular defects.","date":"2019","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31409890","citation_count":14,"is_preprint":false},{"pmid":"32058275","id":"PMC_32058275","title":"ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5.","date":"2020","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/32058275","citation_count":14,"is_preprint":false},{"pmid":"33091686","id":"PMC_33091686","title":"Aberrant functional connectivity between the suprachiasmatic nucleus and the superior temporal gyrus: Bridging RORA gene polymorphism with diurnal mood variation in major depressive disorder.","date":"2020","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/33091686","citation_count":14,"is_preprint":false},{"pmid":"20733416","id":"PMC_20733416","title":"Evaluation of GPR50, hMel-1B, and ROR-alpha melatonin-related receptors and the etiology of adolescent idiopathic scoliosis.","date":"2010","source":"Journal of pediatric orthopedics","url":"https://pubmed.ncbi.nlm.nih.gov/20733416","citation_count":14,"is_preprint":false},{"pmid":"16806533","id":"PMC_16806533","title":"Intracellular localization of RORalpha is isoform and cell line-dependent.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16806533","citation_count":14,"is_preprint":false},{"pmid":"38177186","id":"PMC_38177186","title":"The single-cell transcriptomic atlas and RORA-mediated 3D epigenomic remodeling in driving corneal epithelial differentiation.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38177186","citation_count":13,"is_preprint":false},{"pmid":"38850551","id":"PMC_38850551","title":"More than the clock: distinct regulation of muscle function and metabolism by PER2 and RORα.","date":"2024","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38850551","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49535,"output_tokens":9461,"usd":0.14526,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20374,"output_tokens":5090,"usd":0.11456,"stage2_stop_reason":"end_turn"},"total_usd":0.25982,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"RORα directly activates transcription of Bmal1 through two conserved ROR-response elements (ROREs) in the Bmal1 promoter, functioning as a positive component of the cell-autonomous core circadian clock. Loss of endogenous RORα protein dampens circadian rhythm of Bmal1 transcription.\",\n      \"method\": \"Transient transfection reporter assays, RORE mutagenesis, RNAi knockdown in cultured cells, behavioral analysis of RORα-deficient staggerer mice\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (reporter assay with mutagenesis, RNAi, in vivo genetic mouse model) in a single focused study\",\n      \"pmids\": [\"15821743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RORα1 inhibits TNFα-induced IL-6, IL-8, and COX-2 expression in smooth-muscle cells by reducing p65 translocation and transcriptionally upregulating IκBα via a ROR response element in the IκBα promoter, thereby negatively interfering with the NF-κB signaling pathway.\",\n      \"method\": \"Adenoviral overexpression, Western blotting, immunostaining, EMSA, promoter reporter assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (EMSA, reporter assay, immunostaining, Western blot) in a single rigorous study demonstrating direct RORE-mediated IκBα transactivation\",\n      \"pmids\": [\"11252722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In SCA1 mice, mutant ATXN1 destabilizes RORα, depleting it from Purkinje cells and reducing expression of RORα-controlled genes. Evidence points to existence of a complex containing ATXN1, RORα, and the RORα coactivator Tip60, linking RORα and Tip60 to SCA1 pathogenesis.\",\n      \"method\": \"Conditional transgenic mouse model, Co-immunoprecipitation, gene expression analysis, behavioral assessment\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and conditional mouse model, single lab, two orthogonal approaches\",\n      \"pmids\": [\"17110330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Targeted disruption of the Rora DNA-binding domain produces mice that phenocopy staggerer mice, demonstrating that staggerer defects are caused by absence of functional RORα protein; the null allele fails to complement staggerer, establishing sg as a loss-of-function allele of Rora.\",\n      \"method\": \"Gene targeting in ES cells (null mutation), histological analysis, Northern blot, complementation testing\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — clean genetic null generation with complementation testing and histological/molecular validation\",\n      \"pmids\": [\"9510031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RORα directly regulates the carnitine palmitoyltransferase-1 (CPT-1) and caveolin-3 promoters in skeletal muscle cells, with activity coactivated by p300 and PGC-1, implicating RORα in control of lipid homeostasis in skeletal muscle.\",\n      \"method\": \"Dominant-negative RORα expression, promoter reporter assays, coactivator cotransfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter assays with dominant-negative, single lab, two orthogonal methods\",\n      \"pmids\": [\"15199055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RORα regulates Reverb-α (NR1D1) transcription via a monomeric ROR response element in the Reverb-α promoter; RORα binds this site (demonstrated by EMSA), and GRIP-1/TIF-2 (but not SRC-1) coactivates RORα-stimulated Reverb-α promoter activity.\",\n      \"method\": \"Northern blot, RT-PCR in staggerer mice, transient transfection reporter assays, EMSA, promoter mutagenesis, coactivator cotransfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — EMSA demonstrating direct DNA binding, mutagenesis of RORE, reporter assays, and genetic validation in staggerer mice; multiple orthogonal methods\",\n      \"pmids\": [\"12114512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RORα positively regulates Cyp7b1 (oxysterol 7α-hydroxylase) transcription via ROREs in its promoter; loss of RORα in staggerer mice suppresses Cyp7b1 expression and increases LXRα target gene expression. RORα and LXRα mutually suppress each other in vivo.\",\n      \"method\": \"RORα null (staggerer) mouse analysis, promoter reporter assays, transfection of RORα in hepatocytes, LXR null mouse comparison\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo genetic null combined with promoter reporter assays and reciprocal LXR null comparison, multiple orthogonal methods\",\n      \"pmids\": [\"18055760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RORα is a direct transcriptional target of p53 (contains functional p53 response elements); DNA damage-induced RORα stabilizes p53 in a HAUSP/Usp7-dependent manner and activates a subset of p53 target genes specifically involved in apoptosis.\",\n      \"method\": \"Genome-wide screen, luciferase reporter assays with p53-RE mutagenesis, microarray analysis, Drosophila in vivo apoptosis model\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (reporter/mutagenesis, microarray, in vivo Drosophila model) in a single rigorous study\",\n      \"pmids\": [\"22152482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RORα directly regulates SEMA3F transcription (demonstrated by ChIP and luciferase reporter assay) in breast cancer cells; restoring RORα expression reprograms cancer cells and inhibits tumor invasion in a SEMA3F-dependent manner in 3D culture and nude mouse xenograft.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, 3D culture, siRNA knockdown, xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct promoter occupancy, reporter assay, in vitro and in vivo functional rescue experiments\",\n      \"pmids\": [\"22350413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RORα binds to the heptad repeat and marked box region of E2F1 in a non-canonical pathway, suppressing E2F1-regulated transcription; RORα recruits HDAC1 to the complex to inhibit E2F1 acetylation and DNA-binding activity, thereby inhibiting cell cycle progression.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, HDAC inhibition rescue, reporter assays, siRNA knockdown in mammary epithelial cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reciprocal Co-IP with domain mapping, HDAC rescue, and in vivo mammary phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"24891616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Hepatic RORα controls lipid homeostasis by specifically binding and recruiting HDAC3 to PPARγ target gene promoters, causing transcriptional repression of PPARγ; liver-specific Rorα deletion leads to dysregulation of PPARγ signaling, hepatic steatosis, obesity, and insulin resistance on high-fat diet.\",\n      \"method\": \"Liver-specific Rorα knockout mice, global transcriptome analysis, ChIP, Co-immunoprecipitation with HDAC3, PPARγ antagonist rescue\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — tissue-specific KO with transcriptome, ChIP showing direct promoter occupancy, Co-IP with HDAC3, and pharmacological rescue\",\n      \"pmids\": [\"28757615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RORα/HDAC3 co-recruitment to NF-κB target gene promoters causes dismissal of CBP and BRD4, thereby repressing NF-κB transcriptional activity in intestinal epithelial cells; IEC-specific RORα deletion leads to excessive intestinal inflammation.\",\n      \"method\": \"IEC-specific RORα knockout mice, transcriptome analysis, ChIP, DSS colitis model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — tissue-specific KO with transcriptomics and ChIP showing direct chromatin occupancy with identified co-regulators\",\n      \"pmids\": [\"31570593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Maresin 1 (MaR1), a DHA metabolite, was identified as an endogenous ligand of RORα that enhances RORα expression and transcriptional activity; RORα in turn transcriptionally induces 12-lipoxygenase (12-LOX), a key enzyme in MaR1 biosynthesis, forming a MaR1/RORα/12-LOX autoregulatory circuit.\",\n      \"method\": \"Ligand-binding assays, reporter assays, ChIP, RORα-dependent MaR1 protection experiments in vivo\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays and ChIP, single lab, in vitro and in vivo evidence, but ligand-receptor interaction validation is partially indirect\",\n      \"pmids\": [\"30855276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"20-hydroxyvitamin D3 [20(OH)D3] and 20,23-dihydroxyvitamin D3 function as antagonists/inverse agonists of RORα, inhibiting RORE-driven reporter activity and RORα-target gene (Bmal1, G6pase) promoter activation; molecular modeling with the RORα LBD crystal structure predicts good binding.\",\n      \"method\": \"Tet-on RORα expression system + RORE-LUC reporter, mammalian 2-hybrid LBD-LXXLL assay, molecular modeling using LBD crystal structure\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional reporter assays with LBD interaction assay and molecular modeling, single lab\",\n      \"pmids\": [\"24668754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RORα directly suppresses SOCS3 gene transcription; loss of RORα leads to decreased proinflammatory and increased anti-inflammatory cytokines in retinopathy. Inhibition of SOCS3 abolishes the vasoprotective effects of RORα deficiency, establishing RORα→SOCS3 as a pathway in pathological retinal angiogenesis.\",\n      \"method\": \"RORα genetic deficiency mouse model (oxygen-induced retinopathy), promoter reporter assays, siRNA inhibition of SOCS3\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO, reporter assay, and SOCS3 rescue, single lab\",\n      \"pmids\": [\"26243880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RORα directly binds to a specific ROR response element on the Sema3e promoter and negatively regulates Sema3e promoter-driven transcription; genetic deficiency of RORα induces Sema3e expression in retinal ganglion cells to suppress pathological retinal neovascularization.\",\n      \"method\": \"Promoter-driven luciferase reporter assay, ChIP, AAV2-shRNA knockdown of Sema3e in RORα-deficient mice\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP and reporter assay with direct functional rescue, single lab\",\n      \"pmids\": [\"28646017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RORα directly trans-activates the Il-6 gene in astrocytes (necessary for basal IL-6 levels); after inflammatory stimulation, absence of RORα results in excessive IL-6 upregulation via indirect repression of NF-κB signaling, demonstrating bi-directional regulation of IL-6 by RORα.\",\n      \"method\": \"RORα loss-of-function mutant mice (staggerer), reporter assays, cytokine measurement, immunostaining\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse model with reporter assays and cytokine analysis, single lab\",\n      \"pmids\": [\"19955433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Overexpression of RORα4 in 3T3-L1 cells impairs adipogenesis (decreased adipogenic markers and lipid accumulation); mouse embryonic fibroblasts from staggerer mice differentiate more efficiently into adipocytes, a phenotype reversed by ectopic RORα4 restoration.\",\n      \"method\": \"Overexpression in 3T3-L1, staggerer MEF differentiation assay, ectopic RORα4 rescue\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with rescue experiment in matched cell lines, single lab\",\n      \"pmids\": [\"19450581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Subcellular localization of RORα is isoform- and cell line-dependent: RORα1 localizes exclusively to the nucleus (lacks cytoplasmic signal in its A/B domain), while RORα2, 3, and 4 show cytoplasmic and cell-membrane association. The C-terminal α-helix 12 mediates membrane association; the hinge region/LBD mediates nuclear localization.\",\n      \"method\": \"Isoform-specific expression constructs, domain deletion/swap experiments, subcellular fractionation, immunofluorescence microscopy\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-swap localization experiments with multiple isoforms, single lab\",\n      \"pmids\": [\"16806533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The staggerer mutation is a deletion in the common coding region of RORα isoforms; RORα1 and RORα4 are specifically co-expressed in the murine and human cerebellum, generated by alternative promoter usage and exon splicing, indicating that loss of both isoforms underlies the cerebellar phenotype.\",\n      \"method\": \"High-resolution genetic and physical mapping, RT-PCR isoform analysis, Northern blot in cerebellum\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mapping and molecular characterization, single study, direct mutational analysis\",\n      \"pmids\": [\"9226375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RORα cooperatively binds with RORγt to a previously unidentified Rorc cis-regulatory element to maintain RORγt expression and Th17 lineage stability in peripheral tissues; RORα is dispensable for initial Th17 differentiation but required for optimal Th17 responses in vivo.\",\n      \"method\": \"T-cell-specific RORα conditional KO mice, RNA-seq, ATAC-seq, ChIP-seq\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — conditional KO with ChIP-seq, ATAC-seq, and RNA-seq providing genome-wide mechanistic evidence, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"36243007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In skin-resident Tregs, RORα suppresses IL-4 expression and enhances DR3 (death receptor 3/TL1A receptor) expression; deletion of RORα in Tregs prevents sequestration of TL1A, resulting in enhanced ILC2 activation and exaggerated eosinophilia.\",\n      \"method\": \"Treg-specific RORα conditional deletion mouse models of atopic dermatitis, flow cytometry, cytokine measurement\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with two atopic dermatitis models, single lab\",\n      \"pmids\": [\"29500225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RORα is required for TH17 cell pathogenicity independent of RORγt; T-cell-specific deletion of RORα reduces EAE and colitis development by decreasing TH17 cell development, lowering tissue-homing chemokine receptors/integrins, and increasing Foxp3+ Tregs. A selective RORα antagonist phenocopies the genetic deletion and inhibits human TH17 differentiation.\",\n      \"method\": \"T-cell-specific Rorα conditional KO, EAE and colitis mouse models, pharmacological antagonism with selective small molecule, human TH17 differentiation assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with two disease models replicated pharmacologically and extended to human cells, multiple orthogonal approaches\",\n      \"pmids\": [\"33397953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RORα expression in thymic progenitors represses T cell development while promoting ILC2 development; mechanistically, RORα overrides BCL11B-mediated repression of Nfil3 and Id2, allowing ID2 to repress E proteins and promote ILC2 differentiation over T cell commitment.\",\n      \"method\": \"RNA-seq, ATAC-seq, ChIP-seq, conditional deletion and overexpression mouse models\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-wide ChIP-seq/ATAC-seq/RNA-seq combined with genetic mouse models establishing a transcriptional circuit\",\n      \"pmids\": [\"33432227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RORα promotes mTORC1 activation in CD4+ T cells; genome-wide occupancy (ChIP-seq) and transcriptome analysis reveal RORα as a direct transcriptional driver of mTORC1 pathway genes; Rorα deficiency in CD4+ T cells greatly reduces T cell-mediated colitis.\",\n      \"method\": \"CD4-specific Rorα conditional KO, genome-wide ChIP-seq, RNA-seq, T-cell transfer colitis model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — conditional KO with genome-wide ChIP-seq and transcriptome, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"34525365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RORα directly represses IL-6 transcription in cardiomyocytes; loss of RORα leads to enhanced IL-6 expression, proinflammatory STAT3 activation, decreased mitochondrial number and function, oxidative stress, hypertrophy, and death of cardiomyocytes upon angiotensin II exposure.\",\n      \"method\": \"Staggerer mouse model (in vivo), neonatal rat ventricular myocyte overexpression/silencing (in vitro), luciferase reporter, Western blot\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse model complemented by in vitro gain/loss-of-function and reporter assays, single lab\",\n      \"pmids\": [\"30387679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RORα enhances mitochondrial quality by regulating expression of Bnip3 and PGC-1α; liver-specific RORα knockout mice show mitochondrial fission defects with downregulation of Bnip3 and phospho-Drp1, and are more susceptible to NASH.\",\n      \"method\": \"Liver-specific Rorα KO mice, high-fat diet NASH model, gene expression analysis, oxygen consumption measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO with functional metabolic readouts, single lab\",\n      \"pmids\": [\"29167529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RORα induces transcription of Atp6v1g1 (a vacuolar H+-ATPase subunit) and other lysosomal function genes, thereby enhancing lysosomal acidification and autophagic flux in hepatocytes; hepatocyte-specific RORα deletion impairs lysosomal acidity, mTOR translocation, cathepsin D maturation, and autophagic flux.\",\n      \"method\": \"Hepatocyte-specific Rorα KO mice, LysoSensor assay, LC3/p62/NBR1 accumulation, adenoviral RORα restoration\",\n      \"journal\": \"Hepatology communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO with adenoviral rescue and multiple lysosomal readouts, single lab\",\n      \"pmids\": [\"34558854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RORα regulates macrophage M2 polarization via activation of AMPKα; RORα agonist (cholesterol sulfate) induces M2 markers (Arg1, Ym1, Fizz1) and phosphorylation of AMPKα/ACC; RORα antagonism or AMPKα inhibition abolishes this effect.\",\n      \"method\": \"RORα agonist/antagonist pharmacology in RAW264.7 cells, RORα overexpression, AMPKα inhibitor (Compound C)\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — pharmacological and overexpression approaches with rescue by pathway inhibitor, single lab\",\n      \"pmids\": [\"27788394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RORα protects against LPS-induced inflammation by regulating SIRT1 expression, which in turn affects deacetylation and nuclear translocation of NF-κB p65; specifically, RORα overexpression suppresses acetylation of NF-κB p65 at lysine 310 via SIRT1 upregulation.\",\n      \"method\": \"Lentiviral overexpression/siRNA knockdown in macrophages, LPS model in vivo, SIRT1 agonist rescue experiment\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic rescue with SIRT1 agonist in gain- and loss-of-function settings, single lab\",\n      \"pmids\": [\"31071300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RORA binds the CD274 (PD-L1) promoter and forms an inhibitory complex with HDAC3 to suppress PD-L1 expression; DDX3X competes with HDAC3 for binding to RORA, and DDX3X overexpression promotes RORA release from the repressive complex, increasing PD-L1 expression.\",\n      \"method\": \"ChIP, Co-immunoprecipitation, overexpression/knockdown in melanoma cells, RORA agonist combined with anti-CTLA4 in vivo\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct promoter occupancy, Co-IP establishing the RORA/HDAC3/DDX3X complex, and in vivo pharmacological validation\",\n      \"pmids\": [\"38718296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RORα suppresses superoxide generation in mitochondria by directly targeting respiratory complex I subunit genes NDUFS6 and NDUFA11 (identified by ChIP and gene co-expression), thereby inhibiting ROS-mediated macrophage infiltration and cancer-associated inflammation in breast cancer.\",\n      \"method\": \"Gene co-expression analysis, ChIP, co-culture assay, 4T1 xenograft\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP showing direct promoter occupancy of NDUFS6/NDUFA11, functional co-culture and in vivo validation, single lab\",\n      \"pmids\": [\"34639006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Neoruscogenin (a steroidal sapogenin) was identified as a potent, high-affinity, bioavailable agonist of RORα (NR1F1) using cell-free reporter assays; it activates RORα target gene expression in vitro and in vivo with selectivity over other nuclear receptors.\",\n      \"method\": \"High-throughput cell-free RORα reporter screening, extract deconvolution, structural elucidation, target gene expression assays in vitro and in vivo, nuclear receptor selectivity panel\",\n      \"journal\": \"Journal of biomolecular screening\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based reporter and in vivo target gene validation, single lab\",\n      \"pmids\": [\"23896689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RORA agonist RS-2982 increases hepatic MIR122 promoter activity in hepatocytes; in HFD and atherogenic diet mouse models, RS-2982 increases hepatic MIR122 precursors and reduces hepatic triglyceride biosynthesis by reducing expression of lipogenic enzymes.\",\n      \"method\": \"Chemical library screen, luciferase reporter assays (MIR122 promoter), HFD/atherogenic diet mouse models, in vivo injection\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with in vivo mouse validation, single lab\",\n      \"pmids\": [\"32450149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SORBS2 stabilizes RORA mRNA by directly binding to the 3'UTR of RORA mRNA, reducing its degradation; this post-transcriptional regulation of RORA by SORBS2 mediates SORBS2's anti-tumor effects on HCC cells.\",\n      \"method\": \"RNA immunoprecipitation (RIP), pull-down assay, luciferase reporter (3'UTR), mRNA stability assay\",\n      \"journal\": \"Liver international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP and pull-down assay with functional validation, single lab\",\n      \"pmids\": [\"31365778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The barrel cortex phenotype of staggerer mice results from RORα being cell-autonomously required in the thalamus for thalamocortical axon (TCA) cluster organization, and in the somatosensory cortex for dendritic maturation of layer IV neurons; Sema7a, Neph, and Adcy8 are identified as RORα-regulated genes in this process.\",\n      \"method\": \"Conditional RORα deletion in thalamus or cortex, microarray analysis, histological analysis of barrels/barreloids\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific conditional deletion with microarray, single lab\",\n      \"pmids\": [\"29040410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RORA acts as a CEC-specific molecular switch driving limbal stem cell (LSC) differentiation into corneal epithelial cells by activating PITX1; RORA establishes CEC-specific enhancers and chromatin interactions between CEC gene promoters and distal regulatory elements, while silencing LSC-specific promoters and disrupting promoter-anchored chromatin loops.\",\n      \"method\": \"Single-cell RNA-seq, ChIP-seq, ATAC-seq, Hi-C chromatin interaction analysis, RORA gain/loss-of-function\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-wide epigenomic (ChIP-seq, ATAC-seq, Hi-C) plus single-cell transcriptomics with functional validation, multiple orthogonal methods\",\n      \"pmids\": [\"38177186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RORα and RORγt co-regulate a defined set of human Th17 signature genes including IL-17A, IL-17F, IL-23R, CCL20, and CCR6; siRNA knockdown of RORα in human Th17 cells reduces expression of these key Th17 genes, demonstrating an overlapping but weaker role of RORα versus RORγt.\",\n      \"method\": \"siRNA knockdown (RORγt, RORα), RNA-seq, selective RORγt small molecule modulators as pharmacological controls\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide RNA-seq with siRNA knockdown, parallel pharmacological validation, single lab\",\n      \"pmids\": [\"28763457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RORα mediates induction of osteoarthritis by oxysterol metabolites produced by CH25H and CYP7B1 in chondrocytes; overexpression of CH25H or CYP7B1 causes experimental OA, while knockdown abrogates OA pathogenesis, with RORα acting as downstream effector of cholesterol metabolism changes.\",\n      \"method\": \"Adenoviral overexpression/knockout/knockdown in mouse joints, in vivo OA induction models, epistasis experiments with RORα\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple in vivo genetic manipulation approaches with epistasis placing RORα downstream of CH25H/CYP7B1, replicated in multiple models\",\n      \"pmids\": [\"30728500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-137 directly targets the 3'UTR of RORα in a site-specific manner, establishing a direct biological link between MIR137 and RORA as autism candidate genes.\",\n      \"method\": \"Luciferase 3'UTR reporter assay with site-specific mutagenesis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, single method (luciferase reporter), but site-specific mutagenesis validates the interaction\",\n      \"pmids\": [\"24500708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In skeletal muscle, specific knockout of Rorα (secondary feedback loop) results in aberrant expression of a large number of non-oscillating genes and proteins (rather than primarily affecting circadian oscillation), leading to distinct metabolic and contractile phenotypes compared to PER2 knockout.\",\n      \"method\": \"Muscle-specific Rorα KO mice, global gene expression analysis, metabolomics, muscle function assessment\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with transcriptomics and metabolomics, single lab\",\n      \"pmids\": [\"38850551\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RORA (RORα) is an orphan nuclear receptor that acts as a constitutively active transcription factor binding monomeric ROR-response elements (ROREs) to directly activate target genes (Bmal1, Cyp7b1, CPT-1, Caveolin-3, IL-6, SEMA3F, Reverb-α, NDUFS6/NDUFA11, PITX1) or repress them by recruiting HDAC3 to displace coactivators (CBP, BRD4) from NF-κB and PPARγ target promoters; in the nucleus it can also engage non-canonical partners (E2F1 via its heptad/marked-box domain + HDAC1; HDAC3/DDX3X on the PD-L1 promoter; ATXN1/Tip60 complex in Purkinje cells), and its activity is modulated by endogenous ligands including oxysterols/cholesterol sulfate and the specialized pro-resolving mediator maresin-1; isoform-specific subcellular localization (nuclear for RORα1 via hinge/LBD; cytoplasmic/membrane for RORα2-4 via helix 12) further regulates its activity, while post-transcriptional control by RNA-binding proteins (SORBS2) and miRNAs modulate its protein levels in disease contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RORA encodes RORα, a ligand-modulated nuclear receptor that acts as a constitutively active transcription factor binding monomeric ROR-response elements (ROREs) to direct cell-type-specific gene programs across circadian, metabolic, immune, and developmental contexts [#0, #5, #6]. As a positive arm of the core circadian clock, RORα directly activates Bmal1 and the clock gene Reverb-α through conserved ROREs, with coactivation by GRIP-1/TIF-2 [#0, #5]. Genetic disruption of the RORα DNA-binding domain phenocopies and fails to complement the staggerer allele, establishing staggerer as a loss-of-function mutation in the shared coding region of co-expressed cerebellar isoforms [#3, #19]. Beyond direct activation, RORα executes gene repression by recruiting HDAC3 to displace coactivators CBP and BRD4 from NF-κB target promoters in intestinal epithelium and to silence PPARγ target genes in liver, linking RORα loss to intestinal inflammation, hepatic steatosis, and insulin resistance [#10, #11]. RORα also represses targets through non-canonical protein partnerships: it binds the heptad/marked-box region of E2F1 and recruits HDAC1 to block E2F1 acetylation and cell-cycle progression, and it forms an HDAC3 complex on the CD274 (PD-L1) promoter that DDX3X antagonizes [#9, #30]. In the immune system RORα cooperates with RORγt at a Rorc cis-element to stabilize the Th17 lineage and is independently required for Th17 pathogenicity and mTORC1-driven T-cell programs, while in thymic progenitors it directs ILC2 over T-cell fate by overriding BCL11B repression of Nfil3/Id2 [#20, #22, #23, #24]. RORα controls lipid and oxysterol metabolism through targets including Cyp7b1, CPT-1, and caveolin-3, with reciprocal antagonism toward LXRα, and serves as the downstream effector of CH25H/CYP7B1-generated oxysterols driving osteoarthritis [#4, #6, #38]. Its activity is tuned by endogenous and synthetic ligands—oxysterols, cholesterol sulfate, hydroxyvitamin D3 metabolites, the pro-resolving mediator maresin-1, and synthetic agonists—and isoform-specific localization, with RORα1 confined to the nucleus and RORα2-4 directed to cytoplasm/membrane by C-terminal helix 12 [#12, #13, #18, #28, #38].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Defining the molecular lesion in staggerer mice established that a deletion in the shared coding region of RORα isoforms, ablating cerebellar RORα1 and RORα4, underlies the cerebellar phenotype.\",\n      \"evidence\": \"Genetic/physical mapping and RT-PCR isoform analysis in murine and human cerebellum\",\n      \"pmids\": [\"9226375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish which downstream transcriptional targets mediate the cerebellar defect\", \"Isoform-specific functional differences not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Targeted disruption of the RORα DNA-binding domain proved that staggerer is a loss-of-function allele of Rora, formally tying the phenotype to absent functional RORα protein.\",\n      \"evidence\": \"Gene targeting in ES cells with complementation testing and histological/Northern validation\",\n      \"pmids\": [\"9510031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DNA-binding-independent activities not addressed\", \"Molecular targets in cerebellum not identified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"First mechanistic link of RORα to inflammation showed it antagonizes NF-κB by transactivating IκBα via a RORE, reducing p65 translocation.\",\n      \"evidence\": \"Adenoviral overexpression, EMSA, promoter reporter, immunostaining in smooth-muscle cells\",\n      \"pmids\": [\"11252722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coregulators of this repression not defined here\", \"Did not address direct vs indirect NF-κB target repression\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established RORα as a direct monomeric-RORE transcription factor for the clock gene Reverb-α with coactivator selectivity, defining its DNA-binding mode.\",\n      \"evidence\": \"EMSA, RORE mutagenesis, reporter and coactivator cotransfection, staggerer validation\",\n      \"pmids\": [\"12114512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous ligand control of this activity not addressed\", \"Structural basis of GRIP-1 vs SRC-1 selectivity unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Extended RORα's direct target repertoire to skeletal-muscle lipid genes CPT-1 and caveolin-3, with p300/PGC-1 coactivation, implicating it in muscle lipid homeostasis.\",\n      \"evidence\": \"Dominant-negative RORα, promoter reporter, coactivator cotransfection\",\n      \"pmids\": [\"15199055\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter occupancy not shown by ChIP\", \"In vivo metabolic relevance not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placed RORα as a positive limb of the core circadian clock by demonstrating direct RORE-driven activation of Bmal1.\",\n      \"evidence\": \"Reporter assays with RORE mutagenesis, RNAi, and staggerer behavioral analysis\",\n      \"pmids\": [\"15821743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand regulation of clock activity not addressed\", \"Tissue-specific contributions not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected RORα to neurodegeneration and defined isoform-localization rules, showing mutant ATXN1 destabilizes RORα in Purkinje cells and that helix 12 vs hinge/LBD dictate membrane vs nuclear localization.\",\n      \"evidence\": \"Conditional transgenic SCA1 model with Co-IP; domain-swap fractionation/immunofluorescence\",\n      \"pmids\": [\"17110330\", \"16806533\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ATXN1-RORA-Tip60 complex stoichiometry not resolved\", \"Functional consequence of cytoplasmic isoforms unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined RORα as a regulator of oxysterol/cholesterol metabolism by directly activating Cyp7b1 and mutually antagonizing LXRα.\",\n      \"evidence\": \"Staggerer null analysis, promoter reporters, hepatocyte transfection, LXR-null comparison\",\n      \"pmids\": [\"18055760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of reciprocal RORα/LXRα antagonism not detailed\", \"Ligand identity for endogenous activation not pinned\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Positioned RORα within the DNA-damage/apoptosis axis as both a p53 target and a stabilizer of p53 via HAUSP/Usp7.\",\n      \"evidence\": \"Genome-wide screen, p53-RE mutagenesis reporters, microarray, Drosophila apoptosis model\",\n      \"pmids\": [\"22152482\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RORα-Usp7-p53 biochemistry not fully reconstituted\", \"Selectivity for apoptotic vs other p53 targets unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed non-canonical RORα activity by direct binding to E2F1's heptad/marked-box and HDAC1 recruitment to suppress cell-cycle progression, plus identified vitamin D3 derivatives as inverse agonists.\",\n      \"evidence\": \"Reciprocal Co-IP with domain mapping and HDAC rescue; Tet-on reporter and LBD 2-hybrid with crystal-structure modeling\",\n      \"pmids\": [\"24891616\", \"24668754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of E2F1 repression across cell types not established\", \"Vitamin D3 antagonism shown by modeling/reporter, not co-crystal\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined RORα's HDAC3-dependent repressive mode genome-wide, showing co-recruitment to PPARγ and NF-κB target promoters that controls hepatic lipid homeostasis and intestinal inflammation, with parallel roles in mitochondrial quality and cardiomyocyte protection.\",\n      \"evidence\": \"Tissue-specific KO (liver, IEC), transcriptomics, ChIP, Co-IP with HDAC3, disease models; NRVM gain/loss-of-function\",\n      \"pmids\": [\"28757615\", \"31570593\", \"29167529\", \"30387679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of HDAC3 recruitment to specific promoters unresolved\", \"Coordination of activator vs repressor functions in same cell unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified maresin-1 as an endogenous RORα ligand forming a MaR1/RORα/12-LOX autoregulatory circuit, and linked RORα to SIRT1-mediated NF-κB p65 deacetylation control.\",\n      \"evidence\": \"Ligand-binding, reporter, ChIP, in vivo MaR1 protection; overexpression/knockdown with SIRT1 agonist rescue\",\n      \"pmids\": [\"30855276\", \"31071300\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MaR1-RORα binding partially indirect, lacks structural confirmation\", \"Physiological relevance of MaR1/12-LOX loop in vivo limited\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established RORα as a central regulator of immune cell fate—Th17 pathogenicity, ILC2 vs T-cell commitment, mTORC1 programs, and Treg-mediated TL1A sequestration—largely independent of RORγt.\",\n      \"evidence\": \"Multiple cell-type-specific conditional KOs with ChIP-seq/ATAC-seq/RNA-seq and disease models (EAE, colitis, atopic dermatitis); selective antagonist in human cells\",\n      \"pmids\": [\"33397953\", \"33432227\", \"34525365\", \"29500225\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect targets within each immune program not fully separated\", \"Ligand control of immune RORα activity unaddressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed RORα functions as an epigenomic switch establishing cell-type enhancers and chromatin loops, including driving corneal epithelial differentiation via PITX1 and tuning anti-tumor immunity by controlling PD-L1 through an HDAC3/DDX3X-modulated complex.\",\n      \"evidence\": \"scRNA-seq/ChIP-seq/ATAC-seq/Hi-C with gain/loss-of-function; ChIP and Co-IP with in vivo agonist plus anti-CTLA4\",\n      \"pmids\": [\"38177186\", \"38718296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RORα reorganizes 3D chromatin mechanistically not resolved\", \"Generalizability of PD-L1 DDX3X switch beyond melanoma untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RORα integrates ligand sensing, isoform-specific localization, and the choice between RORE-driven activation versus HDAC-dependent repression to select context-specific gene programs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking ligand identity to activator vs repressor output\", \"Structural basis of partner selection (HDAC3 vs HDAC1 vs DDX3X vs RORγt) undefined\", \"Mechanism directing 3D chromatin remodeling unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 5, 6, 8, 10, 11, 20, 23, 36]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3, 5, 8, 15, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 10, 11, 30]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [12, 13, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5, 18]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [11, 16, 20, 22, 23, 24, 37]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 6, 10, 26, 33, 38]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5, 8, 10, 11, 36]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10, 11, 30, 36]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HDAC3\", \"HDAC1\", \"E2F1\", \"DDX3X\", \"RORC\", \"ATXN1\", \"PPARG\", \"SORBS2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}